Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 34, Issue 10, Pages 581-589Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2013.08.006
Keywords
Hippo pathway; YAP; phosphorylation; GPCR; cancer
Categories
Funding
- National Institutes of Health
Ask authors/readers for more resources
Research in the past decade has revealed key components of the Hippo tumor suppressor pathway and its critical role in organ size regulation and tumorigenesis. Recent progress has identified a wide range of upstream factors that control the Hippo pathway, which include cell cell contact, various diffusible signals, and cognate receptors. Dysregulation of the Hippo pathway, caused by gene mutation or aberrant expression, promotes cell proliferation and tumorigenesis. Here, we discuss the current state of Hippo pathway research, primarily focusing on upstream regulators and protein-protein interactions as potential therapeutic targets. Consideration of pharmacological intervention of the Hippo pathway may provide novel avenues for future therapeutic treatment of human diseases, particularly in cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available